Literature DB >> 3958215

Serum ferritin concentration in sickle cell crisis.

A Brownell, S Lowson, M Brozović.   

Abstract

Serum ferritin, aspartate aminotransferase (AST), alkaline phosphatase and hydroxybutyrate dehydrogenase (HBD) were studied during 21 vaso-occlusive crises in 12 adults with sickle cell disease (11 SS, 1 S beta degrees). The patients comprised three groups: those who had been untransfused (4), those who had received occasional exchange transfusion in crisis (3), and those who had been multiply transfused (5). Serum ferritin concentrations in crisis were compared with those of the steady state value. Rises in serum ferritin concentrations occurred in all crises in all groups. Although AST, alkaline phosphatase, and HBD rose, there was no correlation between these and log ferritin concentrations. The clinical impression was that the degree of rise in ferritin related to the severity of the particular crisis, and the above results showed that haemolysis and liver damage were not causally related to this rise. An estimate of serum ferritin cannot be used to assess the state of iron balance in sickle cell disease unless the patient is in the steady state. The considerable rise in serum ferritin concentration found in crisis, however, may be a useful marker of the extent of vaso-occlusion and tissue damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958215      PMCID: PMC499757          DOI: 10.1136/jcp.39.3.253

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Effect of blood transfusion on iron status in sickle cell anaemia.

Authors:  S Davies; J S Henthorn; A A Win; M Brozovic
Journal:  Clin Lab Haematol       Date:  1984

2.  Iron metabolism, sickle cell disease, and response to cyanate.

Authors:  C M Peterson; J H Graziano; A de Ciutiis; R W Grady; A Cerami; M Worwood; A Jacobs
Journal:  Blood       Date:  1975-10       Impact factor: 22.113

3.  Iron stores in adults with sickle cell anemia.

Authors:  K R Rao; A R Patel; P McGinnis; M K Patel
Journal:  J Lab Clin Med       Date:  1984-05

4.  Iron deficiency in sickle cell anaemia.

Authors:  S Davies; J Henthorn; M Brozović
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

5.  The diagnosis of iron deficiency anemia in sickle cell disease.

Authors:  E Vichinsky; K Kleman; S Embury; B Lubin
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

6.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

7.  Iron burden in sickle cell anemia.

Authors:  R T O'Brien
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

8.  Serum ferritin and dysbaric osteonecrosis.

Authors:  P J Gregg; E J Eastham; J I Bell; D N Walder
Journal:  Undersea Biomed Res       Date:  1977-03
  8 in total
  12 in total

1.  Hyperferritinaemia associated with splenic infarction.

Authors:  M J Pippard; C A Finch
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 2.  Clinical pharmacokinetics of iron preparations.

Authors:  E Harju
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 3.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

4.  Hypoxia-enhanced adhesion of red blood cells in microscale flow.

Authors:  Myeongseop Kim; Yunus Alapan; Anima Adhikari; Jane A Little; Umut A Gurkan
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

5.  Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.

Authors:  Thomas V Adamkiewicz; Miguel R Abboud; Carole Paley; Nancy Olivieri; Melanie Kirby-Allen; Elliott Vichinsky; James F Casella; Ofelia A Alvarez; Julio C Barredo; Margaret T Lee; Rathi V Iyer; Abdullah Kutlar; Kathleen M McKie; Virgil McKie; Nadine Odo; Beatrice Gee; Janet L Kwiatkowski; Gerald M Woods; Thomas Coates; Winfred Wang; Robert J Adams
Journal:  Blood       Date:  2009-08-31       Impact factor: 22.113

6.  Pain frequency, severity and QT dispersion in adult patients with sickle cell anemia: correlation with inflammatory markers.

Authors:  Taysir S Garadah; Ahmed A Jaradat; Mohammed E AlAlawi; Adla B Hassan; Reginald P Sequeira
Journal:  J Blood Med       Date:  2016-10-31

7.  Iron supplementation in pregnant sicklers: an opinion.

Authors:  Desmond Aroke; Diego Nitcheu Tchouakam; Benjamin Momo Kadia; Simeon Pierre Choukem
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-22       Impact factor: 3.007

8.  Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload.

Authors:  Ali Taher; Maria D Cappellini; Elliott Vichinsky; Renzo Galanello; Antonio Piga; Tomasz Lawniczek; Joan Clark; Dany Habr; John B Porter
Journal:  Br J Haematol       Date:  2009-09-18       Impact factor: 6.998

9.  Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria.

Authors:  Akinsegun A Akinbami; Adedoyin O Dosunmu; Adewumi A Adediran; Olajumoke O Oshinaike; Vincent O Osunkalu; Sarah O Ajibola; Olanrewaju M Arogundade
Journal:  J Blood Med       Date:  2013-05-22

10.  Management of cardiac hemochromatosis.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-06-30       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.